← Back to Screener
SiNtx Technologies, Inc. Common Stock (SINT)
Price$2.03
Value ScoreD
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-59.01%
Price vs S&P 500 (4W)-13.61%
VGM Score26.24
Market Capitalization$8.77M
All Metrics
Book Value / Share (Quarterly)$0.22
P/TBV (Annual)5.33x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-13.28%
Cash Flow / Share (Quarterly)$-2.40
Price vs S&P 500 (YTD)-55.57%
Gross Margin (TTM)46.84%
Net Profit Margin (TTM)-1058.60%
EPS (TTM)$-3.39
10-Day Avg Trading Volume0.12M
EPS Excl Extra (TTM)$-3.39
Revenue Growth (5Y)11.38%
EPS (Annual)$-3.74
ROI (Annual)-353.00%
Gross Margin (Annual)45.28%
Net Profit Margin (5Y Avg)-804.34%
Cash / Share (Quarterly)$0.46
Revenue Growth QoQ (YoY)2.98%
ROA (Last FY)-109.03%
Revenue Growth TTM (YoY)-59.95%
EBITD / Share (TTM)$-3.37
ROE (5Y Avg)-199.26%
Operating Margin (TTM)-1121.96%
Cash Flow / Share (Annual)$-2.23
P/B Ratio9.70x
P/B Ratio (Quarterly)11.41x
Net Income / Employee (Annual)$-323,900
EV / Revenue (TTM)6.79x
Net Interest Coverage (TTM)-10363.00x
ROA (TTM)-115.04%
EPS Incl Extra (Annual)$-3.74
Current Ratio (Annual)1.51x
Quick Ratio (Quarterly)0.54x
3-Month Avg Trading Volume0.04M
52-Week Price Return-27.24%
Revenue / Employee (TTM)$32,200
Tangible BV / Share (Quarterly)$0.19
P/S Ratio (Annual)8.61x
Asset Turnover (Annual)0.11x
52-Week High$6.78
Operating Margin (5Y Avg)-892.46%
EPS Excl Extra (Annual)$-3.74
CapEx CAGR (5Y)-12.09%
Tangible BV CAGR (5Y)-35.91%
26-Week Price Return-51.08%
Quick Ratio (Annual)1.16x
13-Week Price Return-26.58%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.04x
Enterprise Value$6.99M
Revenue / Share Growth (5Y)-77.19%
Asset Turnover (TTM)0.11x
Book Value / Share Growth (5Y)-87.63%
Revenue / Employee (Annual)$31,800
Inventory Turnover (Annual)0.84x
Pretax Margin (Annual)-1018.07%
Cash / Share (Annual)$1.06
3-Month Return Std Dev66.84%
Gross Margin (5Y Avg)59.26%
Net Income / Employee (TTM)$-340,400
ROE (Last FY)-353.84%
Net Interest Coverage (Annual)-29.66x
EPS Basic Excl Extra (Annual)$-3.74
Receivables Turnover (TTM)4.46x
Total Debt / Equity (Quarterly)0.12x
EPS Incl Extra (TTM)$-3.39
Receivables Turnover (Annual)5.44x
ROI (TTM)-358.03%
P/S Ratio (TTM)8.52x
Pretax Margin (5Y Avg)-804.34%
Revenue / Share (Annual)$0.37
Tangible BV / Share (Annual)$0.71
Price vs S&P 500 (52W)-51.61%
Year-to-Date Return-47.41%
5-Day Price Return-5.14%
EPS Normalized (Annual)$-3.74
ROA (5Y Avg)-79.77%
Net Profit Margin (Annual)-1018.07%
Month-to-Date Return-9.38%
Cash Flow / Share (TTM)$-4.95
EBITD / Share (Annual)$-3.75
Operating Margin (Annual)-1053.14%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-194.64%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-3.39
P/TBV (Quarterly)13.38x
P/B Ratio (Annual)5.08x
Inventory Turnover (TTM)0.60x
Pretax Margin (TTM)-1058.60%
Book Value / Share (Annual)$0.75
Price vs S&P 500 (13W)-34.84%
Beta0.64x
Revenue / Share (TTM)$0.26
ROE (TTM)-366.49%
52-Week Low$1.86
vGradeD
gGradeD
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.70est. -0.67
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.14
4.14
4.13
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SINTSiNtx Technologies, Inc. Common Stock | D | D | D | $2.03 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
SINTX Technologies Inc manufactures silicon nitride ceramics for biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, and antipathogenic with strong bone affinity characteristics. The company's silicon nitride spinal implants have achieved clinical adoption in the US, Europe, Brazil, and Taiwan.